References

References1. Ervine RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report 2009;13:1–8.ErvineRBPrevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race ethnicity, and body mass index: United States, 2003–2006.Natl Health Stat Report2009131-82. Hoang KC, Le TV, Wong ND. The metabolic syndrome in East Asians. J Cardiometab Syndr 2007;2:276–282.HoangKC]]LeTV]]WongNDThe metabolic syndrome in East Asians.J Cardiometab Syndr20072276-2823. Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr 2008;17(suppl 1):37–42.PanWH]]YehWT]]WengLCEpidemiology of metabolic syndrome in Asia.Asia Pac J Clin Nutr20081737-424. Reynolds K, Gu D, Whelton PK, et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring) 2007;15:10–18.ReynoldsK]]GuD]]WheltonPK&etal;Prevalence and risk factors of overweight and obesity in China.Obesity (Silver Spring)20071510-185. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Executive Summary. May, 2001. National Institutes of Health. National Heart, Lung and Blood Institute. NIH publication number 01–3670.6. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation, 2006. Avenue Emile De Mot 19, B-1000 Brussels, Belgium7. DECODE Study Group. Does diagnosis of the metabolic syndrome detect further men and high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. Eur J Cardiovasc Prev Rehabil 2007;14:192–199.DECODE Study GroupDoes diagnosis of the metabolic syndrome detect further men and high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.Eur J Cardiovasc Prev Rehabil200714192-1998. Girman CJ, Rhodes T, Mercuri M, et al; 4S Group, AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136–141.GirmanCJ]]RhodesT]]MercuriM&etal;4S GroupAFCAPS/TexCAPS Research GroupThe metabolic syndrome and risk of major coronary events in the Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).Am J Cardiol200493136-1419. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093–1100.GrundySMMetabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.J Am Coll Cardiol2006471093-110010. Blaha MJ, Bansal S, Rouf R, et al. A practical “ABCDE” approach to the metabolic syndrome. Mayo Clin Proc 2008;83:932–943.BlahaMJ]]BansalS]]RoufR&etal;A practical “ABCDE” approach to the metabolic syndrome.Mayo Clin Proc200883932-94311. Lin CY, Su SB, Chang CC, et al. The association between Chlamydia pneumoniae and metabolic syndrome in Taiwanese adults. South Med J 2009;102:1203–1208.LinCY]]SuSB]]ChangCC&etal;The association between Chlamydia pneumoniae and metabolic syndrome in Taiwanese adults.South Med J20091021203-1208